Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neuroblastoma 16Central Nervous System Neoplasms 13Brain Neoplasms 9Medulloblastoma 8Rhabdoid Tumor 6Astrocytoma 6Sarcoma 5Glioma 5Oligodendroglioma 4Lymphoma 4Pinealoma 3Osteosarcoma 3Optic Nerve Glioma 3Ependymoma 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Spinal Cord Neoplasms 2Rhabdomyosarcoma 2Recurrence 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Glioblastoma 2Ganglioneuroblastoma 2Familial ependymoma 2Drug-Related Side Effects and Adverse Reactions 2Choroid Plexus Neoplasms 2

Interventions

Filgrastim 8Granulocyte Colony-Stimulating Factor 7Thiotepa 6Etoposide 5Carboplatin 5Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Busulfan 4Melphalan 3Ifosfamide 3Topotecan 2Mesna 2sargramostim 1racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1etoposide phosphate 1cixutumumab 1becatecarin 1alvocidib 1Vincristine 1Ursodeoxycholic Acid 1Thrombopoietin 1Thalidomide 1Temozolomide 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Retinoblastoma × etoposide phosphate × CNS × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡